Role of death receptor pathway in estradiol-induced T-cell apoptosis in vivo

Toxicological Sciences

Volumn 70, Issue 1, 2002, Pages 63-72

  Do, Yoonkyung ^a   Ryu, Seongho ^a   Nagarkatti, Mitzi ^a   Nagarkatti, Prakash S ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

Author keywords

Apoptosis; Estrogen; Fas; FasL; Immunotoxicity; Thymus

Indexed keywords

CASPASE; CASPASE 8; CASPASE INHIBITOR; COMPLEMENTARY DNA; ESTRADIOL VALERATE; FAS LIGAND; NITRIC OXIDE SYNTHASE; PROTEIN BCL 2; STAPHYLOCOCCUS ENTEROTOXIN A; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; CASP8 PROTEIN, MOUSE; CASP9 PROTEIN, MOUSE; CASPASE 9; DRUG DERIVATIVE; ENTEROTOXIN; ENTEROTOXIN A, STAPHYLOCOCCAL; ENZYME INHIBITOR; ESTRADIOL; FAS ANTIGEN; FASL PROTEIN, MOUSE; MEMBRANE PROTEIN;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL PROLIFERATION; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DNA MICROARRAY; FEMALE; GENE EXPRESSION; IMMUNOCYTOTOXICITY; IN VIVO STUDY; MITOCHONDRION; MOUSE; NONHUMAN; RECEPTOR UPREGULATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; T LYMPHOCYTE; THYMOCYTE; THYMUS ATROPHY; ANIMAL; ATROPHY; C57BL MOUSE; CELL COUNT; CELL DIVISION; CHEMICALLY INDUCED DISORDER; CYTOLOGY; DRUG ANTAGONISM; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETICS; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; MOUSE MUTANT; PATHOLOGY; THYMUS; UPREGULATION;

ANIMALIA; BACTERIA (MICROORGANISMS); STAPHYLOCOCCUS;

ANIMALS; ANTIGENS, CD95; APOPTOSIS; ATROPHY; CASPASE 8; CASPASE 9; CASPASES; CELL COUNT; CELL DIVISION; ENTEROTOXINS; ENZYME INHIBITORS; ESTRADIOL; FAS LIGAND PROTEIN; FEMALE; GENE EXPRESSION REGULATION; LYMPHOCYTE ACTIVATION; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED C57BL; MICE, MUTANT STRAINS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; T-LYMPHOCYTES; THYMUS GLAND; UP-REGULATION;

EID: 0036850414     PISSN: 10966080     EISSN: None     Source Type: Journal    
DOI: 10.1093/toxsci/70.1.63     Document Type: Article

References (40)

1. Aroeira, L. S., and Martinez, A. C. (1999). The role of IL-4 in the staphylococcal enterotoxin B-triggered immune response: Increased susceptibility to shock and deletion of CD8Vβ8+ T cells in IL-4 knockout mice. Eur. J. Immunol. 29, 1397-1405.
2. Ashwell, J. D., Lu, F. W., and Vacchio, M. S. (2000). Glucocorticoids in T cell development and function. Annu. Rev. Immunol. 18, 309-345.
3. Barnden, M. J., Heath, W. R., and Carbone, F. R. (1997). Down-modulation of CD8 beta-chain in response to an altered peptide ligand enables developing thymocytes to escape negative selection. Cell. Immunol. 175, 111-119.
4. Bornstein, J., Kaufman, R. H., Adam, E., and Adler-Storthz, K. (1987). Human papillomavirus associated with vaginal intraepithelial neoplasia in women exposed to diethylstilbestrol in utero. Obstet. Gynecol. 70, 75-80.
5. Brunelli, R., Frasca, D., Baschieri, S., Spano, M., Fattorossi, A., Mosiello, L. F., D'Amelio, R., Zichella, L., and Doria, G. (1992). Changes in thymocyte subsets induced by estradiol administration or pregnancy. Ann. N. Y. Acad. Sci. 650, 109-114.
6. Couse, J. F., and Korach, K. S. (1999). Estrogen receptor null mice: What have we learned and where will they lead us? Endocr. Rev. 20, 358-417.
7. Cutolo, M., Sulli, A., Seriolo, B., Accardo, S., and Masi, A. T. (1995). Estrogens, the immune response and autoimmunity. Clin. Exp. Rheumatol. 13, 217-226.
8. Degen, G. H., and Bolt, H. M. (2000). Endocrine disruptors: Update on xenoestrogens. Int. Arch. Occup. Environ. Health 73, 433-441.
9. Esaki, T., Hayashi, T., Muto, E., Kano, H., Kumar, T. N., Asai, Y., Sumi, D., and Iguchi, A. (2000). Expression of inducible nitric oxide synthase and Fas/Fas ligand correlates with the incidence of apoptotic cell death in atheromatous plaques of human coronary arteries. Nitric Oxide 4, 561-571.
10. Giglio, T., Imro, M. A., Filaci, G., Scudeletti, M., Puppo, F., De Cecco, L., Indiveri, F., and Costantini, S. (1994). Immune cell circulating subsets are affected by gonadal function. Life Sci. 54, 1305-1312.
11. Giusti, R. M., Iwamoto, K., and Hatch, E. E. (1995). Diethylstilbestrol revisited: A review of the long-term health effects. Ann. Intern. Med. 122, 778-788.
12. Hengartner, M. O. (2000). The biochemistry of apoptosis. Nature 407, 770-776.
13. Hirahara, H., Ogawa, M., Kimura, M., Iiai, T., Tsuchida, M., Hanawa, H., Watanabe, H., and Abo, T. (1994). Glucocorticoid independence of acute thymic involution induced by lymphotoxin and estrogen. Cell. Immunol. 153, 401-411.
14. Holladay, S. D., Blaylock, B. L., Comment, C. E., Heindel, J. J., Fox, W. M., Korach, K. S., and Luster, M. I. (1993). Selective prothymocyte targeting by prenatal diethylstilbestrol exposure. Cell. Immunol. 152, 131-142.
15. Hughes, D. E., Dai, A., Tiffee, J. C., Li, H. H., Mundy, G. R., and Boyce, B. F. (1996). Estrogen promotes apoptosis of murine osteoclasts mediated by TGF-beta. Nat. Med. 2, 1132-1136.
16. Ju, S. T., Matsui, K., and Ozdemirli, M. (1999). Molecular and cellular mechanisms regulating T and B cell apoptosis through Fas/FasL interaction. Int. Rev. Immunol. 18, 485-513.
17. Kamath, A. B., Camacho, I., Nagarkatti, P. S., and Nagarkatti, M. (1999). Role of Fas-Fas ligand interactions in 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD)-induced immunotoxicity: Increased resistance of thymocytes from Fas-deficient (lpr) and Fas ligand-defective (gld) mice to TCDD-induced toxicity. Toxicol. Appl. Pharmacol. 160, 141-155.
18. Kamath, A. B., Nagarkatti, P. S., and Nagarkatti, M. (1998). Characterization of phenotypic alterations induced by 2,3,7,8-tetrachlorodibenzo-p-dioxin on thymocytes in vivo and its effect on apoptosis. Toxicol. Appl. Pharmacol. 150, 117-124.
19. Kamath, A. B., Xu, H., Nagarkatti, P. S., and Nagarkatti, M. (1997). Evidence for the induction of apoptosis in thymocytes by 2,3,7,8-tetrachlorodibenzo-p-dioxin in vivo. Toxicol. Appl. Pharmacol. 142, 367-377.
20. Lai, Z. W., Fiore, N. C., Hahn, P. J., Gasiewicz, T. A., and Silverstone, A. E. (2000). Differential effects of diethylstilbestrol and 2,3,7,8-tetrachlorodibenzo-p-dioxin on thymocyte differentiation, proliferation, and apoptosis in bcl-2 transgenic mouse fetal thymus organ culture. Toxicol. Appl. Pharmacol. 168, 15-24.
21. Luster, M. I., Hayes, H. T., Korach, K., Tucker, A. N., Dean, J. H., Greenlee, W. F., and Boorman, G. A. (1984). Estrogen immunosuppression is regulated through estrogenic responses in the thymus. J. Immunol. 133, 110-116.
22. Melnick, S., Cole, P., Anderson, D., and Herbst, A. (1987). Rates and risks of diethylstilbestrol-related clear-cell adenocarcinoma of the vagina and cervix. An update. N. Engl. J. Med. 316, 514-516.
23. Mor, G., Munoz, A., Redlinger, R., Jr., Silva, I., Song, J., Lim, C., and Kohen, F. (2001). The role of the Fas/Fas ligand system in estrogen-induced thymic alteration. Am. J. Reprod. Immunol. 46, 298-307.
24. Okasha, S. A., Ryu, S., Do, Y., McKallip, R. J., Nagarkatti, M., and Nagarkatti, P. S. (2001). Evidence for estradiol-induced apoptosis and dysregulated T cell maturation in the thymus. Toxicology. 163, 49-62.
25. Okuyama, R., Abo, T., Seki, S., Ohteki, T., Sugiura, K., Kusumi, A., and Kumagai, K. (1992). Estrogen administration activates extrathymic T cell differentiation in the liver. J. Exp. Med. 175, 661-669.
26. Rijhsinghani, A. G., Thompson, K., Bhatia, S. K., and Waldschmidt, T. J. (1996). Estrogen blocks early T cell development in the thymus. Am. J. Reprod. Immunol. 36, 269-277.
27. Robertson, C. N., Roberson, K. M., Padilla, G. M., O'Brien, E. T., Cook, J. M., Kim, C. S., and Fine, R. L. (1996). Induction of apoptosis by diethylstilbestrol in hormone-insensitive prostate cancer cells. J. Natl. Cancer. Inst. 88, 908-917.
28. Ruggiero, R. J., and Likis, F. E. (2002). Estrogen: Physiology, pharmacology, and formulations for replacement therapy. J. Midwifery Womens Health 47, 130-138.
29. Safe, S. H., Pallaroni, L., Yoon, K., Gaido, K., Ross, S., Saville, B., and McDonnell, D. (2001). Toxicology of environmental estrogens. Reprod. Fertil. Dev. 13, 307-315.
30. Screpanti, I., Morrone, S., Meco, D., Santoni, A., Gulino, A., Paolini, R., Crisanti, A., Mathieson, B. J., and Frati, L. (1989). Steroid sensitivity of thymocyte subpopulations during intrathymic differentiation. Effects of 17 beta-estradiol and dexamethasone on subsets expressing T cell antigen receptor or IL-2 receptor. J. Immunol. 142, 3378-3383.
31. Shevde, N. K., and Pike, J. W. (1996). Estrogen modulates the recruitment of myelopoietic cell progenitors in rat through a stromal cell-independent mechanism involving apoptosis. Blood 87, 2683-2692.
32. Silverstone, A. E., Frazier, D. E., Jr., Fiore, N. C., Soults, J. A., and Gasiewicz, T. A. (1994). Dexamethasone, beta-estradiol, and 2,3,7,8-tetrachlorodibenzo-p-dioxin elicit thymic atrophy through different cellular targets. Toxicol. Appl. Pharmacol. 126, 248-259.
33. Staples, J. E., Fiore, N. C., Frazier, D. E., Jr., Gasiewicz, T. A., and Silverstone, A. E. (1998). Overexpression of the anti-apoptotic oncogene, bcl-2, in the thymus does not prevent thymic atrophy induced by estradiol or 2,3,7,8-tetrachlorodibenzo-p-dioxin. Toxicol. Appl. Pharmacol. 151, 200-210.
34. Staples, J. E., Gasiewicz, T. A., Fiore, N. C., Lubahn, D. B., Korach, K. S., and Silverstone, A. E. (1999). Estrogen receptor alpha is necessary in thymic development and estradiol-induced thymic alterations. J. Immunol. 163, 4168-4174.
35. Tai, X. G., Toyo-oka, K., Yamamoto, N., Yashiro, Y., Mu, J., Hamaoka, T., and Fujiwara, H. (1997). Expression of an inducible type of nitric oxide (NO) synthase in the thymus and involvement of NO in deletion of TCR-stimulated double-positive thymocytes. J. Immunol. 158, 4696-4703.
36. Tornwall, J., Carey, A. B., Fox, R. I., and Fox, H. S. (1999). Estrogen in autoimmunity: Expression of estrogen receptors in thymic and autoimmune, T cells. J. Gend. Specif. Med. 2, 33-40.
37. Vermes, I., Haanen, C., Steffens-Nakken, H., and Reutelingsperger, C. (1995). A novel assay for apoptosis. Flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled Annexin V. J. Immunol. Methods 184, 39-51.
38. Welshons, W. V., Murphy, C. S., Koch, R., Calaf, G., and Jordan, V. C. (1987). Stimulation of breast cancer cells in vitro by the environmental estrogen enterolactone and the phytoestrogen equol. Breast Cancer Res. Treat. 10, 169-175.
39. Yellayi, S., Teuscher, C., Woods, J. A., Welsh, T. H., Jr., Tung, K. S., Nakai, M., Rosenfeld, C. S., Lubahn, D. B., and Cooke, P. S. (2000). Normal development of thymus in male and female mice requires estrogen/estrogen receptor-alpha signaling pathway. Endocrine 12, 207-213.
40. Zava, D. T., Blen, M., and Duwe, G. (1997). Estrogenic activity of natural and synthetic estrogens in human breast cancer cells in culture. Environ. Health Perspect. 105(Suppl. 3), 637-645.